跳至主要内容
临床试验/IRCT20210730052027N1
IRCT20210730052027N1招募中2 期

Evaluation of therapeutic effects of crocina (saffron tablets) in patients with polycystic ovary syndrome: a randomized double-blind clinical trial

Yazd University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 44 years(—)
性别
Female

入选标准

  • Age 18 to 44 years
  • Adequate literacy to understand the study, drug use and potential side effects
  • Patient known with polycystic ovary syndrome

排除标准

  • Serious medical conditions that the patient cannot regularly attend periodic visits include severe cardiovascular disease such as angina or myocardial infarction, recent stroke, psychiatric disorders, active concussion, and anemia
  • Taking estrogenic or progestin drugs to regulate the monthly cycle
  • Antidepressants (SSRI, SNRI, TCA, MAOI6)
  • Failure to sign written consent
  • Pregnancy and lactation

研究者

发起方
Yazd University of Medical Sciences

相似试验